About cyanotech - CYAN
Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye, joint, and immune health, and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI.
CYAN At a Glance
Cyanotech Corp.
73-4460 Queen Kaahumanu Highway
Kailua-Kona, Hawaii 96740-2637
| Phone | 1-808-326-1353 | Revenue | 26.59M | |
| Industry | Pharmaceuticals: Other | Net Income | -1,282,000.00 | |
| Sector | Health Technology | 2026 Sales Growth | 9.796% | |
| Fiscal Year-end | 03 / 2027 | Employees | N/A | |
| View SEC Filings |
CYAN Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.082 |
| Price to Book Ratio | 0.284 |
| Price to Cash Flow Ratio | 9.36 |
| Enterprise Value to EBITDA | 9.90 |
| Enterprise Value to Sales | 0.488 |
| Total Debt to Enterprise Value | 0.894 |
CYAN Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | N/A |
| Receivables Turnover | 8.188 |
| Total Asset Turnover | 1.166 |
CYAN Liquidity
| Current Ratio | 1.016 |
| Quick Ratio | 0.424 |
| Cash Ratio | 0.076 |
CYAN Profitability
| Gross Margin | 32.625 |
| Operating Margin | -2.159 |
| Pretax Margin | -4.803 |
| Net Margin | -4.822 |
| Return on Assets | -5.621 |
| Return on Equity | -15.498 |
| Return on Total Capital | -6.657 |
| Return on Invested Capital | -10.394 |
CYAN Capital Structure
| Total Debt to Total Equity | 151.41 |
| Total Debt to Total Capital | 60.224 |
| Total Debt to Total Assets | 52.42 |
| Long-Term Debt to Equity | 49.112 |
| Long-Term Debt to Total Capital | 19.535 |